Repligen reported $40.4M in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Agilent A:US USD 368M 39M
Align Technology ALGN:US USD 41.78M 30.92M
Bio Techne TECH:US USD 50M 39.55M
Biomarin Pharmaceutical BMRN:US USD -6652000 34.32M
Bristol Myers Squibb BMY:US USD 2.02B 416M
Bruker BRKR:US USD 88.1M 38.6M
Charles River Laboratories CRL:US USD 96.47M 12.85M
Danaher DHR:US USD 2.23B 660M
Dentsply International XRAY:US USD -1077000000 1.15B
Exact Sciences EXAS:US USD -148761000 17.3M
Fluidigm FLDM:US USD -29426000 34.11M
General Electric GE:US USD 2.22B 2.39B
Henry Schein HSIC:US USD 150M 10M
Illumina ILMN:US USD -3816000000 3.28B
IQVIA Holdings Inc IQV:US USD 283M 27M
Mettler Toledo International MTD:US USD 220.6M 8.53M
Myriad Genetics MYGN:US USD -35100000 21M
Orasure Technologies OSUR:US USD 5.27M 24.08M
Patterson Companies PDCO:US USD 54.07M 29.48M
Peregrine Pharmaceuticals PPHM:US USD -1156000 2.72M
Perkinelmer PKI:US USD 85.35M 93.86M
Pfizer PFE:US USD 5B 3.61B
Repligen RGEN:US USD 40.4M 9.46M
Thermo Fisher Scientific TMO:US USD 1.58B 81M
Waters WAT:US USD 156M 8.87M
West Pharmaceutical Services WST:US USD 120.6M 67.9M